Cost-effectiveness of budesonide Turbuhaler in the treatment of mild-to-moderate asthma in Japan

Asthma therapy including inhaled corticosteroids (ICS) has been shown to be effective in many parts of the world, but its use is still limited in Japan. A 6-week, randomized, placebo-controlled, clinical trial was therefore undertaken to assess the efficacy of the ICS budesonide Turbuhaler (budesoni...

Full description

Bibliographic Details
Main Authors: Terumasa Miyamoto, Shiro Fujino, Shigenori Nakajima, Ulf Tollemar, Bengt Liljas
Format: Article
Language:English
Published: Elsevier 1999-01-01
Series:Allergology International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893015314957